可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Wilcken DE, Wilcken B.The pathogenesis of coronary artery disease. A possible role for methionine metabolism[J]. J Clin Invest,1976,57(4):1079-1082.
[2]Genest JJ, Mcnamara JR, Salem DN, et al. Plasma homocysteine levels in men with premature coronary artery disease[J]. J Am Coll Cardiol,1990,16:1114-1119.
[3]Boushey CJ, Beresford AA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease:probable benefits of increasing folic acid intake[J].JAMA,1995,274:1049-1057.
[4]闫韵洪,张利华. 同型半胱氨酸与冠状动脉粥样硬化的相关性.心脏杂志[J].2002,14(4):303-304.
[5]Selhub J,Jacques PF,Wilson PWF, et al. Vitamins status and intake as primary determinants of homocysteinemia in an elderly population [J]. JAMA,1993,270(22):2693-2698.
[6]陈军. 血浆同型半胱氨酸与冠心病患者年龄的关系[J].心脏杂志,2000,12(3):251-252.
[7]Glueck CF,Shaw P,Lang F, et al .Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidenic patients[J]. Am J Cardiol,1995,75:132-135.
[8]Nygard O,Vollset SE,Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile [J]. JAMA,1995,274:1526-1533.